These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 8489670)
21. Household survey of child-safe packaging for medications. Gulaid JA; Hadsall RS; Sacks JJ; Wertheimer AI Public Health Rep; 1990; 105(4):430-2. PubMed ID: 2116650 [TBL] [Abstract][Full Text] [Related]
22. Childhood poisoning: a community hospital experience. Gehlbach SH; Wall JB South Med J; 1977 Jun; 70(6):674-6. PubMed ID: 877615 [TBL] [Abstract][Full Text] [Related]
23. Compounding for treatment of toxicosis. Bagley CV J Am Vet Med Assoc; 1994 Jul; 205(2):214-7. PubMed ID: 7928580 [No Abstract] [Full Text] [Related]
24. Primary packaging considerations in developing medicines for children: oral liquid and powder for constitution. Campbell GA; Vallejo E J Pharm Sci; 2015 Jan; 104(1):52-62. PubMed ID: 25393927 [TBL] [Abstract][Full Text] [Related]
25. Human exposure to pet prescription medications. Bryant SM; Mycyk MB Vet Hum Toxicol; 2002 Aug; 44(4):218-9. PubMed ID: 12136968 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy. Karara AH; Hines R; Demir Z; Nnorom B; Horsey R; Twigg G Int J Pharm Compd; 2016; 20(6):461-467. PubMed ID: 28339384 [TBL] [Abstract][Full Text] [Related]
27. Extralabel drug use and compounding in veterinary medicine. Geyer RE Food Drug Law J; 1997; 52(3):291-5. PubMed ID: 10343027 [No Abstract] [Full Text] [Related]
28. Tamper-evident packaging requirements for over-the-counter human drug products--FDA. Final rule. Fed Regist; 1998 Nov; 63(213):59463-71. PubMed ID: 10187120 [TBL] [Abstract][Full Text] [Related]
29. Evaluations of safety packaging for the protection of children. Done AK; Jung AL; Wood MC; Klauber MR Pediatrics; 1971 Oct; 48(4):613-28. PubMed ID: 5114749 [No Abstract] [Full Text] [Related]
30. Manufacturing of drugs: interpretation of federal regulations lies in eye of beholder. Raef TA J Am Vet Med Assoc; 1990 May; 196(9):1360-1. PubMed ID: 2341312 [No Abstract] [Full Text] [Related]
31. [Multi-dose packaging of drugs as the causative vehicle for multidrug-resistant Enterobacter cloacae: new results from a case-control study]. Hermes J; Jansen A; Geipel U; Herrmann M; von Müller L; Haber M; Jung W; Thomé-Granz S; Eckmanns T Gesundheitswesen; 2011 Nov; 73(11):778-83. PubMed ID: 22113386 [TBL] [Abstract][Full Text] [Related]
33. Making childhood safer. Child-resistant containers for prescription medications: current status and use survey. Shenkel RC J Kans Med Soc; 1972 Feb; 73(2):56-7 passim. PubMed ID: 5008711 [No Abstract] [Full Text] [Related]
34. Choosing a Vial Processing Line for Aseptic Compounding: Part 1. Noorian S; Vahedi N Int J Pharm Compd; 2016; 20(4):283-292. PubMed ID: 28333673 [TBL] [Abstract][Full Text] [Related]
36. Veterinary compounding in small animals: a clinical pharmacologist's perspective. Boothe DM Vet Clin North Am Small Anim Pract; 2006 Sep; 36(5):1129-73, viii. PubMed ID: 16984830 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of child-resistant packaging on toxin procurement in young poisoning victims. Lembersky RB; Nichols MH; King WD Vet Hum Toxicol; 1996 Oct; 38(5):380-3. PubMed ID: 8888549 [TBL] [Abstract][Full Text] [Related]
38. FDA-CVM asks for veterinary input on responsible compounding of drugs. Raef TA J Am Vet Med Assoc; 1990 Oct; 197(8):967. PubMed ID: 2243048 [No Abstract] [Full Text] [Related]
39. Progress in the prevention of childhood iron poisoning. Woolf A; Litovitz T Arch Pediatr Adolesc Med; 2005 Jun; 159(6):593-5. PubMed ID: 15939862 [No Abstract] [Full Text] [Related]
40. Letter: Accidental injection of Immobilon. Volans GN; Whittle BA Br Med J; 1976 Aug; 2(6033):472-3. PubMed ID: 953617 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]